Introduction: Multiple sclerosis (MS) is a chronic, inflammatory, and autoimmune disease of the central nervous system that affects approximately 2.9 million people worldwide (1,2). Progressive forms of MS are defined by a gradual worsening of neurological function, independent of relapses. This progression can begin from the onset, known as primar